NEWS ARCHIVE

Tag: bioprinting

Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…

We’re extremely excited to announce the launch of our second Regulation A+ equity crowdfunding campaign. Due to popular demand, we have re-opened the opportunity to invest in BIOLIFE4D’s life-saving technology! Since our first equity crowdfunding campaign, we’ve made exceptional progress – including the successful demonstration of 3D bioprinting human tissue, along with heart components like chambers,…

If you couldn’t tell, we’re beyond excited about our big announcement coming this September. While we are on our way to the ultimate goal of 3D bioprinting a human heart for transplant, we figured now is as good a time as any to reflect on our achievements so far and highlight some of our monumental…

  If you can’t tell, we’re pretty excited. We have so much to share with you, and we think you’ll be pretty excited about it too. The only problem is we can’t … not yet. But once September is here get ready, because what we have to show you will blow you away. Our team,…

It’s the middle of February so we all know what that means – red hearts everywhere to celebrate a special holiday. If you’re thinking about Valentine’s Day, you wouldn’t be wrong. But this week we are recognizing another heart-based campaign – Heart Failure Awareness Week. In 2001 the Heart Failure Society of America, with support…

After a yearlong tremendously successful equity crowdfunding campaign, the ability to acquire equity in BIOLIFE4D and participate in the groundbreaking technology is quickly coming to an end.  There are now only 24 hours left to invest in BIOLIFE4D before the opportunity to do so closes – this Thursday January 31, 2019! Earlier this weekwe announced the appointment…

Company names Dr. Michael Davidson, Mr. Stephen Simes, Dr. Mark Weinberg, and Mr. Bruce Werner as strategic advisors CHICAGO – January 28, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a Management Advisory Board to offer strategy and leadership…

We’re down to the wire. In just one week we’ll be closing the opportunity to invest in BIOLIFE4D through our equity crowdfunding campaign. This is your last chance to be able to participate with us in bringing this incredible technology to the market.  It is your last chance to get in on the ground floor…

Heart disease kills more human beings than anything else on earth each year, accounting for 18 million deaths – about 31% of all global deaths. Solving heart disease has been one of humanity’s greatest challenges since the beginning of medicine but sadly, scientists have not been able to figure it out. The impact of deaths from…

The beginning of each year is a great time to get a lot of things in order, and one of those is finances and investments. Many people invest in vehicles like index funds that spread their money across a large number of companies, and often don’t keep track of where their money goes. At the…

Build a Heart. Save a life.

Scroll Up